Ignite Creation Date:
2024-05-05 @ 7:35 PM
Last Modification Date:
2024-10-26 @ 9:50 AM
Study NCT ID:
NCT00690378
Status:
COMPLETED
Last Update Posted:
2018-05-25
First Post:
2008-05-29
Brief Title:
Comparative Study of NXL104Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
Prospective Multicenter Investigator-blinded Randomized Comparative Study Estimate Safety Tolerability Efficacy of NXL104Ceftazidime vs Comparator Followed Appropriate Oral Therapy Treatment Complicated UTI Hosp Adults
Status:
COMPLETED
Status Verified Date:
2018-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether NXL104 plus ceftazidime is effective in the treatment of complicated urinary tract infections as compared to a comparator group
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| C3591013 | OTHER | Alias Study Number | None |